Cushing's disease
1 paper
- Humans1
Trial sponsors
Novartis Pharmaceuticals Corporation
Company1 trialPhase 4249 people
Latest
ENDO 2025 Abstract
SUN-075 Efficacy of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) for Diabetes Management in Patients with Cushing’s Disease
Cohort study of 15 peopleGLP-1 receptor agonists